LML134
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LML134, covering 2016-10-27 to 2019-09-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Wakefulness Promoting Effect, Safety, Tolerability, and Pharmacokinetics (PK) of LML134 in Shift Work Disorder [Phase 2]